Vistagen Therapeutics, Inc. (VTGN)
0.2388
0.00 (0.00%)
USD |
NASDAQ |
Sep 10, 14:57
Vistagen Therapeutics Market Cap : 10.60M for Sept. 10, 2026
Market Cap Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Market Cap Data
| Date | Value |
|---|---|
| September 09, 2026 | 10.45M |
| September 08, 2026 | 10.80M |
| September 04, 2026 | 10.78M |
| September 03, 2026 | 10.93M |
| September 02, 2026 | 10.92M |
| September 01, 2026 | 10.80M |
| August 31, 2026 | 11.32M |
| August 28, 2026 | 11.22M |
| August 27, 2026 | 11.41M |
| August 26, 2026 | 11.54M |
| August 25, 2026 | 11.02M |
| August 24, 2026 | 10.82M |
| August 21, 2026 | 10.83M |
| August 20, 2026 | 10.70M |
| August 19, 2026 | 10.83M |
| August 18, 2026 | 10.74M |
| August 17, 2026 | 11.54M |
| August 14, 2026 | 11.88M |
| August 13, 2026 | 11.82M |
| August 12, 2026 | 11.59M |
| August 11, 2026 | 11.94M |
| August 10, 2026 | 10.45M |
| August 07, 2026 | 11.39M |
| August 06, 2026 | 11.24M |
| August 05, 2026 | 11.77M |
| Date | Value |
|---|---|
| August 04, 2026 | 11.89M |
| August 03, 2026 | 9.707M |
| July 31, 2026 | 9.548M |
| July 30, 2026 | 9.548M |
| July 29, 2026 | 9.640M |
| July 28, 2026 | 9.224M |
| July 27, 2026 | 9.121M |
| July 24, 2026 | 8.97M |
| July 23, 2026 | 8.954M |
| July 22, 2026 | 9.267M |
| July 21, 2026 | 9.311M |
| July 20, 2026 | 9.156M |
| July 17, 2026 | 9.081M |
| July 16, 2026 | 9.509M |
| July 15, 2026 | 9.862M |
| July 14, 2026 | 9.751M |
| July 13, 2026 | 10.01M |
| July 10, 2026 | 10.22M |
| July 09, 2026 | 9.873M |
| July 08, 2026 | 9.303M |
| July 07, 2026 | 9.386M |
| July 06, 2026 | 9.739M |
| July 02, 2026 | 9.862M |
| July 01, 2026 | 9.628M |
| June 30, 2026 | 8.954M |
Market Capitalization Definition
Market Capitalization measures the total value of a company based on their stock price multiplied by the shares outstanding. This metric is important because it gives you an idea of the size of a company, and how the size has changed over time. When studying companies from a relative basis, it would make sense to compare companies that have a similar market capitalization because factors like market share, economies of scale, and business models would also be similar.
Market Cap Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Market Cap Benchmarks
| ACADIA Pharmaceuticals, Inc. | 4.753B |
| Alnylam Pharmaceuticals, Inc. | 33.21B |
| Anika Therapeutics, Inc. | 278.50M |
| Savara, Inc. | 1.083B |
| Vericel Corp. | 1.936B |
Market Cap Related Metrics
| PS Ratio | 3.832 |
| Price to Book Value | 0.4329 |
| Price | 0.2388 |
| Earnings Yield | -713.9% |